The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior.
about
The Neurobiology of the Switch Process in Bipolar DisorderReview of pharmacological treatment in mood disorders and future directions for drug development.Molecular actions and clinical pharmacogenetics of lithium therapyDeletion of glutamate delta-1 receptor in mouse leads to aberrant emotional and social behaviorsAmygdalar glutamatergic neuronal systems play a key role on the hibernating state of hamsters.Presynaptic glutamatergic dysfunction in bipolar disorderChronic lithium treatment elicits its antimanic effects via BDNF-TrkB dependent synaptic downscalingA kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors.Does gene deletion of AMPA GluA1 phenocopy features of schizoaffective disorder?The amygdala excitatory/inhibitory balance in a valproate-induced rat autism modelProof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments.Antidepressant-like activity of magnesium in the olfactory bulbectomy model is associated with the AMPA/BDNF pathway.Expression of the AMPA Receptor Subunits GluR1 and GluR2 is Associated with Granule Cell Maturation in the Dentate Gyrus.The Role of Nutrients in Protecting Mitochondrial Function and Neurotransmitter Signaling: Implications for the Treatment of Depression, PTSD, and Suicidal Behaviors.Dynamic increases in AMPA receptor phosphorylation in the rat hippocampus in response to amphetamine.Rapid glutamate receptor 2 trafficking during retinal degeneration.3'-Deoxyadenosine (Cordycepin) Produces a Rapid and Robust Antidepressant Effect via Enhancing Prefrontal AMPA Receptor Signaling Pathway.The beneficial effects of leptin on REM sleep deprivation-induced cognitive deficits in miceThe Prefrontal Dectin-1/AMPA Receptor Signaling Pathway Mediates The Robust and Prolonged Antidepressant Effect of Proteo-β-Glucan from Maitake.Dynamic regulation of mitochondrial function by glucocorticoids.Targeting the glutamatergic system to develop novel, improved therapeutics for mood disordersEvidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers.Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.Search for common targets of lithium and valproic acid identifies novel epigenetic effects of lithium on the rat leptin receptor gene.A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder.Electrophysiological Characterization of AMPA and NMDA Receptors in Rat Dorsal Striatum.Glutamate Neurotransmission in Psychotic Disorders and Substance Abuse.Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania.A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder.Chronic valproate attenuates some, but not all, facets of mania-like behaviour in mice.Is neurogenesis relevant in depression and in the mechanism of antidepressant drug action? A critical review.Lithium's role in neural plasticity and its implications for mood disordersResearch review: the role of cytokines in depression in adolescents: a systematic review.NMDA antagonists under investigation for the treatment of major depressive disorder.The role of F-actin in modulating Clathrin-mediated endocytosis: Lessons from neurons in health and neuropsychiatric disorder.Involvement of metabotropic glutamate receptor 5 in the inhibition of methamphetamine-associated contextual memory after prolonged extinction training.Heteromeric channels formed by TRPC1, TRPC4 and TRPC5 define hippocampal synaptic transmission and working memory.Gestational exposure to inorganic arsenic (iAs3+) alters glutamate disposition in the mouse hippocampus and ionotropic glutamate receptor expression leading to memory impairment.Early postnatal exposure to lithium in vitro induces changes in AMPAR mEPSCs and vesicular recycling at hippocampal glutamatergic synapses.Influence of an interaction between lithium salts and a functional polymorphism in SLC1A2 on the history of illness in bipolar disorder.
P2860
Q22241114-030C6A92-6703-49C7-A4E5-A28926302ED0Q26853509-A745521A-3DE7-48C7-9FFA-35DA0881D658Q28307770-733431B2-FCC5-4FF4-B258-5C1E7222E52CQ28512821-A03EB50E-19CD-4B7D-A617-9113DAADA11DQ33798598-3B6C24E9-0ABB-4350-83A4-C13A392FAE2AQ33857903-5B8A3983-A0E4-47AE-BDD1-9A9D3E858C83Q33879254-DE46F477-79BD-49AA-8B04-CE94CF011CBCQ33953387-22100764-B53E-4C38-BAF5-927FA70CC50EQ34203814-3E309FA6-C690-4339-BF11-AD2FDD52A427Q34576258-1084FEC8-27B0-45A0-8409-0E30A53F31BDQ34766451-124F41CA-4DF2-41A1-99F0-B873A092F4D7Q34978637-1ABDE6F7-6405-475F-9869-B5FFF2716A31Q35202053-7DC45AFD-C0C5-4AF5-B69D-B910480DD78FQ35563633-B67974B1-44CC-4AEC-827F-94B67F02C844Q35732475-5D141A1E-DE4B-4C05-B312-80DFDA374FF3Q35811938-05C4FD58-8E8B-43AE-85CE-7082530569B8Q36852383-9DAB42B0-32BB-46D2-BDB0-2BBBCA8B1CC6Q36914498-B8BA4709-556E-422F-87A7-AAF3BC7B664FQ37027915-B8770C01-EA3D-4552-AEAF-5B0F61F80290Q37087119-64378921-84A3-4B84-9B24-22F3C0901805Q37143117-0197E23D-27B9-4877-8C85-4B451F3E6732Q37159843-385F521B-EB7A-4122-8CA8-3B39D9AE373BQ37164665-203C5A09-4C01-4DE4-B203-9777BF9A7334Q37347610-E8B8362F-D382-4F9C-9351-8B7A0390B2CAQ37395509-5B3124FC-737A-4430-B646-B962B4793680Q37398453-0DB255BA-D6D4-449F-B933-085D7B973EFAQ37412503-0ACB6E18-3E96-4973-B065-A68261583C8BQ37461666-A70EB047-7275-4FB1-8A1B-C6C9F1FF6C01Q37536783-3AFD8D1A-E8E0-4709-8436-B3DAB2C50A74Q37577518-4614A1FD-CBBF-47D7-BB98-B61B250B0542Q37969149-30E43C81-4D89-446F-A07C-FA7CA0AC62E1Q38101644-30091AB3-72E8-4FE8-9F3C-ED6227CFBF8AQ38136672-B4920706-B10E-434A-B7A9-3FA620A1697AQ38211107-75671E41-BDB8-47C5-BB2D-94F46FED8EE5Q38233039-934C9AC3-534C-469A-99BB-1C3BB215E0E9Q40125735-91BFE4EB-AE9C-46A6-BEB3-191FF185D7C9Q47651471-02EEE11C-CA6B-41D7-BD8E-F4D4E29AE854Q47769743-F344A183-23B2-4633-A4E7-E5B43154FB03Q48183124-0A493AC0-85D4-4826-BD2D-12BDDB7D802CQ48356710-CEB3C31E-5ED3-457A-9C1C-D4635012F904
P2860
The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior.
@en
The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior.
@nl
type
label
The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior.
@en
The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior.
@nl
prefLabel
The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior.
@en
The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior.
@nl
P2093
P2860
P1476
The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior.
@en
P2093
Cynthia Falke
Guang Chen
Husseini K Manji
Neil A Gray
Peixiong Yuan
Rayah Blumenthal
Thomas K Creson
P2860
P356
10.1523/JNEUROSCI.3080-07.2008
P407
P577
2008-01-01T00:00:00Z